Although the connection of AKR1C3 with ROS regulation has already been indicated in prostate cancer and ESCC, these studies mainly focused on radiation resistance, and the underlying molecular mechanism of the regulatory role of AKR1C3 with ROS is not well investigated [31,32]. The gene discussed is AKR1C3; the disease is prostate carcinoma.